China’s marine pharmaceuticals and functional products industry added value rose
to 99.6 bln yuan in 2025 from more than 30 bln yuan in 2012, according to a 2026
report released by the Ministry of Natural Resources. The industry is led by the
eastern marine economic belt, with northern and southern regions catching up.
China leads the world in marine natural product discoveries, and AI has raised
drug-screening efficiency by more than 100-fold. The report also cites
breakthroughs in clinical trials for marine drugs and global-leading supply of
several key raw materials. Applications of marine biological products are
expanding in medical materials, enzyme preparations and agricultural products.